Twenty intercalating agents were tested to examine the effects of intercalating dye-induced perturbations upon the antiviral activity of poly (adenylate-uridylate) [poly (A-U)]. Neither poly (A-U) alone nor each intercalative dye was an efficacious antiviral agent. When poly (A-U) was combined with major groove intercalating dyes (acridine orange or proflavine), no synergism was observed. When poly (A-U) was combined with minor groove intercalating dyes [ethidium (EB), propldium (PI), adriamycin (ADR) or daunomycin (DMN)] or minor/major groove intercalating dyes [9-aminoacridine (9-AA), N 2-methyl-9-hydroxy-ellipticine (NMHE) or N 2,N6-dimethyl-9-hydroxy-ellipticine (DMHE)] the 50% effective doses (ED so ) of the poly (A-U), 9-AA, ADR, DMHE, DMN, EB, NMHE and PI decreased 18-22-60-, , , 274-,61-,154-,113-and 299-fold, respectively. When poly (A-U) was combined individually with 11 dyes whose mode of intercalation was not known, the ED so of ametantrone (HAQ), chloroquine (CHL), mitoxantrone (DHAQ) and quinine (QUI) decreased 125-,65-, 251-and 32-fold, respectively. These results suggest that the four dyes may intercalate into poly (A-U) from the minor groove. Ten (ADR, CHL, DMN, DHAQ, DMHE, EB, HAQ, NMHE, PI, QUI) of the 20 dyes evaluated exhibited significant synergism with poly (A-U), as quantified by the fractional inhibitory concentration index. Interferon (IFN) neutralization assays demonstrated that the IFN-inducing capability ofthe dye/poly (A-U) combinations approximated the sum of the capabilities of the poly (A-U) and the dyes employed. These results suggest that the majority of the dyes tested potentiate the antiviral activity of poly (A-U) without affecting the amount of IFN induced.
Introduction
Human interferon-beta (IFN-f3) has clinical importance due to its broad spectrum of antiviral activities (Levy, 1980; Torrence and De Clercq, 1984) and its direct anti-tumour effects (Pitha and Kusiak, 1984; Greene et el., 1984) . Double-stranded RNAs (dsRNA) , such as polyriboinosinic-polyribocytidylic acid [poly (I)' poly (C)] and poly (adenylate-uridylate) [poly (A-U)]. are the most potent, least toxic and most widely active inducers of IFN-f3 both in vivo and in vitro (Pitha and Kusiak, 1984; Greene et a/., 1984) . Poly (A-U) is of special interest because it has been shown to possess a potentiated antiviral activity and an enhanced resistance to endonuclease degradation when it is thermally activated in the presence of divalent cations (Ca 2 +, Mg 2 +) (De Clercq et sl., 1971; De Clercq, 1977) . Diederich et al. (1972 Diederich et al. ( , 1973 observed that cationic dyes also potentiate the antiviral and IFN-inducing activities of dsRNA. Sehgal et al. (1975) demonstrated that while neutral red or chloroquine alone are not effective IFN inducers, treatment of human diploid fibroblasts with these dyes 2.5-3.5 hours after poly (I) . poly (C)treatment potentiated IFN induction 16-64-fold and 4-16-fold respectively. The fact that the dyes employed by these investigators exhibited a structural homology with intercalative acridines suggests that a dye-nucleic acid interaction may be responsible for the enhanced antiviral activity. To test this hypothesis, we have designed experiments to examine and quantify the modulation of the antiviral and IFN-inducing activities of poly (A-U) and poly (guanylatecytidylate) [poly (G-C)] by a series of intercalative dyes ( Fig. 1) for which the precise nature of the intercalation has been elucidated. These intercalative dyes may be divided into three classes, which are distinguished by their directional entrance into double-stranded nucleic acids (Sobell et el., 1977; Tsai, 1978) .The first class of dyes intercalates exclusively from the minor groove and includes ethidium bromide and daunomycin. The second class of dyes intercalates exclusively from the major groove and includes acridine orange and proflavine. The third class of intercalative dyes may intercalate from either the minor or major groove and includes N 2-methyl-9-hydroxy-ellipticine (NMHE), N 2,N6-dimethyl-9-hydroxy-ellipticine (DMHE) and 9-aminoacridine. Representatives from each of these three classes are employed in this study. 
Results
The first set of experiments examined the antiviral activity of each of the dyes poly (A-U) and poly (G-C) individually for concentrations ranging from 0.0008mM to O.4mM (fable 1). The antiviral activity of the polyribonucleotides increased as a function of increasing polyribonucleotide concentration, until the equivalent IFN titres plateaued at a polyribonucleotide concentration of 0.2 mM. Poly (A-U) and poly (G-C) attained optimal equivalent IFN titres of approximately 1300 units mr' and 1600 units rnl" at a concentration of O.4mM. Ethidium (EB) and DMHE attained optimal equivalent IFN titres of 400 units mr', while adriamycin (ADR) and daunomycin (DMN) attained optimal equivalent IFN titres of 800 units mr', The NMHE, propidium (PI) and the acridine orange (AO) displayed optimal equivalent IFN titres of 530,670 and 1100 units mr', Due to its limited solubility, 9-aminoacridine (9-AA) was evaluated at a concentration of 0.1 mM, where it exhibited an equivalent IFN titre of 400 units ml".
The average 50% effective doses (ED 5 0 ) of the polyribonucleotides and the dyes are shown below. Poly (A-U) and poly (G-C) possessed an average 5D 50 of 6.8 ± 4.5 11M and 5.9 ± 4.1 11M. The EB, PI, ADR, and DMN exhibited ED 50 values of 15.4 ± 7.7 11M, 20.9 ± 7.8 11M, 13.5 ± 7.2 11M and 11.1 ± 7.7 11M. Finally, DMHE, NMHE, 9-AA and AO displayed ED 50 values of 21.9 ± 2.3 11M, 17.6 ± 1.9I1M, 13.0 ± 2.8 11M and 14.3 ± 3.3 11M. These results indicate that neither of the polyribonucleotides nor any of the dyes alone was an efficacious antiviral agent.
The second set of experiments examined the ability of intercalative dyes to modulate the antiviral activity of polyribonucleotides. These intercalative dyes fall into three classes: those that intercalate1[om the minor groove of double-helical nucleic acid, those that intercalate from the major groove and those that intercalate from either the major or minor groove. All dyes from each class were tested in conjunction with poly (A-U). However, due to a limited supply of poly (G-C), only one dye from each class was tested in conjunction with poly (G~C). In these Table 1 . Antiviral activity of poly (A-U), poly (G-C) and the intercalative agents alone. ND  ND  ND  ND  ND  ND  ND  ND  0.0063  ND  ND  ND  ND  ND  ND  ND  ND  ND  ND Mean equivalent IFN titres are the arithmetic averages of six readings, except as noted (a = triplicate readings). The antiviral activities of poly (A-U), poly (G-C), and each intercalative dye alone were tested for concentrations ranging from 0.0008 mMto 0.4 mM.Each of the solutions was serially diluted with PBS in 12 twofold dilutions to form test solutions. These test solutions were co-incubated with HSF cells for 3 h at 37"C. SUbsequently, the test solutions were removed and the cells are washed twice with 100 flol PBS, overlain with 50 flol EMEM (5% FCS), incubated for 17h at 37"C and challenged with VSV (MOl = 0.1). Antiviral activity was evaluated by 50% CPE 17 h post-infection. ND, not detected; NT, not tested.
experiments, the concentration of the polyribonucleotide was fixed at 0.2mM while the dye concentration was varied to produce dye/ribonucleotide ratios of 1/16, 1/8, 1/6, 1/4, 1/2, 1/1 and 2/1. Due to its limited solubility, 9-M was evaluated at polyribonucleotide concentrations of 0.1mM. Four minor groove intercalating dyes were examined in this study: EB, PI, ADR, and DMN ( Fig. 1) . In all cases, the addition of dye enhanced the antiviral activity of the polyribonucleotides with the magnitude of enhancement depending on the dye/ribonucleotide ratio (Tables 2 and  3 ). The four dyes tested were divided into two categories on the basis of the dye/ribonucleotide ratio that produced the optimal enhancement of antiviral activity. The first category was represented by two phenanthridine dyes, EB and PI. For these two phenanthridines, the equivalent IFN titres increased as the EB (or PI)/ribonucleotide ratios increased, reaching a maximum at an EB (or PI)/ribonucleotide ratio in the region of 1/4, and remained constant or decreased slightly as the EB (or PI)/ribonucleotide ratios approached 2/1. Conversely, the ratios of the 50% effective doses (ED so ) decreased as the EB (or PI)/ribonucleotide ratios increased, reached a minimum at an EB (or PI)/ribonucleotide ratio in the region of 1/4, and increased as the EB (or PI)/ribonucleotide ratios approached 2/1. Since the equivalent IFN titres of the EB/poly (A-U) combinations (Table 2) were not significantly different from the equivalent IFN titres of the EB/poly (G-C) Mean equivalent IFN titres are the arithmetic averages of six readings, except as noted (a = triplicate readings). Mean 50% effective doses are the geometric averages of six readings, except as noted (a = triplicate readings). The role of EB or DMN in modulating the antiviral activities of poly (A-U) and poly (G-C) was examined by experiments in which the concentration of the poly (A-U) and poly (G-C) were fixed at 0.2 mM, while EB or DMN concentrations were varied to produce EB or DMN/poly (A-U) or EB or DMN/poly (G-C) ratios ranging from 1 : 16 to 2: 1. Each of these EB or DMN/poly (A-U) and EB or DMN/poly (G-C) solutions were serially diluted with PBS in 12 twofold dilutions to form test solutions. These test solutions were co-incubated with HSF cells for 3 h at 37°C. SUbsequently, the test solutions were removed and the cells washed twice with 100 p.lPBS, overlain with 50 flol EMEM (5% FCS), incubated for 17 hat 37"C and challenged with VSV (MOl = 0.1). Antiviral activity was evaluated by 50% CPE 17 h post-infection.
DIP, drug/ribonucleotide ratio. Mean equivalent IFN titres are the arithmetic averages pf six readings, except as noted (a = triplicate readings).
Mean 50% effective doses are the geometric averages of six readings, except as noted (a = triplicate readings). Modulation of the antiviral activities of poly (A-U) by PI, ADR, NMHE or DMHE was examined by experiments in which the concentration of the poly (A-U) was fixed at 0.2 mM,while the test agent concentrations were varied to produce test agent/poly (A-U) ratios ranging from 1 : 16 to 2 : 1. Each of these solutions was serially diluted with PBS in 12 twofold dilutions to form test solutions. These test solutions were co-incubated with HSF cells for 3 h at 37"C. Subsequently, the test solutions were removed and the cells washed twice with 100 fLlPBS, overlain with 50'fLi EMEM (5% FCS), incubated for 17 h at 37°C and challenged with VSV (MOl = 0.1). Antiviral activity was evaluated by 50% CPE 17h post-infection, D/P, drUg/ribonucleotide ratio. combinations (27700 units mr' compared to 25600 units mr' at a D/P ratio of 1/4), the potentiation of the antiviral activity of the polyribonucleotides by ethidium does not appear to be sensitive to the base sequence of the poly (A-U) or poly (G-C). In addition, the equivalent IFN titres (Tables 2 and 3) of the EB/polyribonucleotide combinations were not significantly different from the equivalent IFN titres of the PI/polyribonucleotide combinations (27700 units rnr' compared to 25600 units rnr' at a D/P ratio of 1/4). These results suggest that the enhancement process is not affected by the alkyl substituent or the additional positive charge of the propidium iodide. The equivalent IFN titres of the EB (or PI)/polyribonucleotide combinations exceeded the sum of the equivalent IFN titres of their constituents. For example, the equivalent IFN titre of the 0.2 mM poly (A-U) alone was 1100 units mr', while the equivalent IFNtitre of the ethidium bromide alone at the concentration employed to produce an EB/ribonucleotide ratio of 1/4 was 180 units rnl". When ethidium bromide was combined with poly (A-U) in a ratio of 1/4, the equivalent IFN titre was 27700 units rnl" (a 22-fold enhancement). The enhancement phenomenon is more striking when one examines the ED so values. The average ED so for EB alone was 1504fLM, while the average ED so for poly (A-U) alone was 6.9 fLM. When EB was combined with 0.2 mMpoly (A-Uytoproduce an EB/poly (A-U) ratio of 1 :4, the ratio of ED so was 0.10/0040.These results demonstrate that when EB is combined with poly (A~U), the ED so of the poly (A-U) decreases from 6.9 fLM to 004fLM (a 17-fold decrease), while the ED so of the poly (A-U) decreases from 1504fLM to 0.10 fLM (a 154-fold decrease). A similar potentiation of antiviral activity was observed for the PI/polyribonucleotide combinations.
The second category of minor groove intercalating dyes is represented by ADR and DMN, whose equivalent IFN titres (Tables2 and 3) increased as the ADR (or DMN)/ribonucleotide ratios increased, reached a maximum at an ADR (or DMN)/ribonucleotide ratio in the region of 1/6, and remained constant or decreased slightly as the ADR (or DMN)/ribonucleotide ratios approached 2/1. in a ratio of 1/6, the equivalent IFN titre was 25600 units mr' (a 17-fold enhancement). When 0.033mM DMN was combined with 0.2 mM poly (A-U), the ED so of the poly (A-U) decreased from 6.9 fLM to 0.36 fLM (an 18-fold decrease), while the ED so of the DMN decreased from 11.1 fLM to 0.06 fLM (an 185-fold decrease). A similar potentiation of antiviral activity was observed for the ADRIpolyribonucleotide combinations. The fractional inhibitory concentration index (FIC; Elion et al., 1954; Suhnel, 1990 ) was employed to evaluate synergism, additivism or antagonism. The minor groove intercalating dyes EB, PI, DMN, and ADR exhibited a significant synergism in combination with poly (A-U) at the concentrations employed in this study, with FIG of 0.065, 0.045, 0.095, and 0.166, respectively. Three major/minor groove intercalating dyes were tested in this study: 9-AA, DMHE and NMHE. As was the case for the minor groove intercalating dyes, addition of the dyes enhanced the antiviral activity of the polyribonucleotides with the magnitude of enhancement depending on the dye/ribonucleotide ratio. For all three dyes, the ED 50 decreased as the dye/ribonucleotide ratios increased, reaching a minimum at a dye/ribonucleotide ratio in the region of 1/4, and then increased as the dye/ribonucleotide ratios approached 2/1. However, the three dyes tested can be divided into two categories on the basis of the degree of enhancement of antiviral activity.
The first category of major/minor intercalating dyes included: DMHE and NMHE. The equivalent IFN tit res of the NMHE/poly (A-U) combinations were not significantly different from the equivalent IFN titres of the DMHE/poly (A-U) combinations (Table 3 ). These results suggest that the enhancement phenomenon is not affected by the methylation of the indolic nitrogen of the NMHE (Fig. 1) . Furthermore, the equivalent IFN titres of the NMHE (or DMHE)/poly (A-U) combinations exceeded the sum of the equivalent IFN titres of their constituents. The equivalent IFN titre of the 0.2 mM poly (A-U) alone was 1100 units rnr", while the equivalent interferon titre of 0.05 mMNMHE alone was 70 units mr' .When NMHE was combined with Intercalating dyes and RNA 337 poly (A-U) in a ratio of 1/4, the equivalent IFN titre was 19200 units mr' (a 16-fold enhancement). When 0.05 mM NMHE was combined with 0.2 mM poly (A-U), the ED 50 of the poly (A-U) decreased from 6.9/LM to 0.28/LM(a 25-fold decrease), while the ED 50 of the NMHE decreased from 17.6/LMto 0.07/LM (a251-fold decrease). A similar potentiation of antiviral activity was observed for the DMHE/polyribonucleotide combinations.
The second category was represented by 9-AA (Table  4) , which produced only marginal enhancement of the antiviral activity of the polyribonucleotides. Since the equivalent IFN titres of the 9-ANpoly (A-U) combinations were not significantly different from the equivalent IFN titres of the 9-ANpoly (G-C) combinations (4300 units rnr' compared to 5300 units rnr' at a D/P ratio of 1/4), the potentiation of the antiviral activity of the polyribonucleotides by 9-aminoacridine does not appear to be sensitive to the.base sequence of the poly (A-U) or poly (G-C). The equivalent IFN titre of the 0.1 mMpoly (A-U) alone was 730 units mr' ,while the equivalent IFNtitres of 0.025 mM9-AA alone was 100 units rnl" . When 9-AA was combined with poly (A-U) in a ratio of 1/4, the equivalent IFN titre exceeded the sum of the equivalent IFN titres of the constituents (4300 units rnr' ,asixfold-enhancement), the ED 50 of the poly (A-U) decreased from 6.9/LMto 2.40 /LM (a threefold decrease), and the ED 5 0 of the 9-AA decreased from 13.0/LM to 0.60/LM (a 22-fold decrease). This suggests a positive synergism between the poly (A-U) and the major/minor groove intercalating dyes at the concentrations employed in this study. The minor/major groove Table 4 . Antiviral activity of AO/polyribonucleotide and 9-AA1polyribonucleotide combinations. AO/ribonucleotide 9-AA1ribonucleotide" Mean equivalent IFN titres are the arithmetic averages of triplicate readings. Mean 50% effective doses are the geometric averages of triplicate readings. Modulation of the antiviral activities of poly (A-U) and poly (G-C) by the role of AO or 9-M was examined by experiments in which the concentration of the poly (A-U) and poly (G-C) was fixed at 0.2 mM (or 0.1 mM), while the AO (or 9-M) concentrations were varied to produce AO (or 9-M)/ polyribonucleotide ratios ranging from 1 : 16 to 2: 1. Each of these solutions was serially diluted with PBS in 12 twofold dilutions to form test solutions. These test solutions were co-incubated with HSF cells for 3 h at 37"C. Subsequently, the test solutions were removed and the cells washed twice with 100fLi PBS, overlain with 50fLi EMEM (5% FCS), incubated for 17h at 37"C and challenged with VSV (MOl = 0.1). Antiviral activity was evaluated by 50% CPE 17 h post-infection. D/P, drug/ribonucleotide ratio. NA, not applicable. a. Tested with ribonucleotide concentration of 0.1 mM. Two major groove intercalating dyes were tested: acridine orange (AO) and proflavine (PRO). The equivalent IFN titres (Table 4 ) of the AO/polyribonuleotide combinations were greatly reduced compared to the equivalent IFN titres ( Table 2 and 3) of the EB (or Pl)/polyribonucleotide combinations. An equivalent IFN titre of 3200 units mr' was the largest enhancement of antiviral activity and occurred with an AO/poly (G-C)ratio of 2/1, where the poly (G-C) concentration was fixed at 0.2 mM. The resulting equivalent IFN titres of the AO/polyribonucleotide combinations were essentially equal to the sum of the equivalent IFN titres of the two constituents. Proflavine, another major groove intercalator, was tested with 0.2 mM poly (A-U) only at a ratio of 1/4 ( Table 5 ). Like the AO/polyribonucleotide combinations, the PRO/poly (A-U) combination did not display potentiated antiviral activity. There was no apparent synergism between the poly (A-U) and the major groove intercalating dyes at the concentrations employed in this study.
The third set of experiments evaluated the role of 11 additional dyes in modulating the antiviral activity of poly (A-U). To facilitate comparison, the dyes evaluated in the previous tables have also been added to Table 5 . In these experiments, the 0.2 mMpoly (A-U)alone, the 0.05 dye test solutions alone, or each 0.05 dye test solution in combination with 0.2 mM poly (A-U) were tested for antiviral activity. The results of previous studies (Tsai et aI., 1988) suggested that the majority of intercalative dyes produce maximum enhancement of the antiviral activity of poly (A-U) when the dye/ribonucleotide ratio is 1/4. Since the equivalent IFNtitres for the 1/4 and the 1/6 dye/nucleotide ratios in the ADR and DMN studies were identical with the error of the technique, it was decided to standardize the screening protocol to a dye/nucleotide ratio of 1/4. Test agent/poly (A-U) combinations that exhibited at least an eightfold enhancement in antiviral-activity were considered to be active. Employing this criterion, 10 of the 20 dyes tested in this study produced an eiqht-to 22-fold enhancement in the antiviral activity of poly (A-U). In this study, the fractional inhibitory concentration (FIG) index (Elion et al., 1954; SOhnel, 1990) Initial assessments of cytotoxicity were made by microscopic examination of human foreskin fibroblast (HSF) cell morphology. Alteration of normal cell morphology, such as cell rounding or detachment of HSF cells from the microtitre plate was considered as exhibiting cytotoxicity. Employing these criteria, cytotoxicity was observed for DHAQ or NMHE alone at concentrations ;:;:0.025 mM;ADR, DMHE, DMN or EB alone at concentrations ;:;:0.05 mM; HAQ alone at concentrations ;:;:0.2 mM; and for ADR (or DHAQ, DMN, HAQ)/poly (A-U) combinations with D/P ratlos > 1/2 and ADR (or DHAQ, DMN, HAQ) concentrations ;:;: 0.05 mM. No cytotoxicity was observed when cell monolayers were treated with poly (A-U), 9-AA, GHL, PI or QUI alone; for any of the 9~AA (or GHL, PI, QUI)/poly (A-U) combinations; or for ADR (or DHAQ, DMN, HAQ)/poly (A-U) combinations with D/P ratios s; 1/4.
The fourth set of experiments examined the ability of ethidium bromide to modulate the antiviral activity of polynucleotides with other base sequences. For these experiments, the concentration of the polynucleotides was fixed at 0.2 mM, while the concentration of EB was fixed at 0.05 mM, to produce an EB/poly (I) . poly (0) ratio of 1/4. In contrast to the antiviral activity of the EB/poly (A-U) combinations, the antiviral activity of the other polynucleotides was not affected by the addition of EB (Table 6 ). The equivalent IFN titre of 0.2mM poly (I) • poly (0) alone was 14900 units ml" (ED so = 0.71 f.LM). When the 0.2 mM poly (I) . poly (0) was combined with 0.05 mM EB, the equivalent IFN titre decreased to 8500 units mr'
(ratio of ED so = 0.28/1.28). Neither 0.2 mM poly d(A-1) alone nor the EB/poly d(A-1) combination exhibited antiviral activity. These results suggest that potentiated antiviral 0.32/1.28 NI Mean equivalent IFN titres are the arithmetic averages of six readings. Mean 50% effective doses are the geometric averages of six readings. The role of EB in modulating the antiviral activity of polynucleotides was examined by experiments in which the concentration of the polynucleotide was fixed at 0.2 mM, while the EB concentration was fixed at 0.05 mM to produce an EB/polynucleotide ratio of 1 :4. Each of these EB/polynucleotide solutions was serially diluted with PBS in 12 twofold dilutions to form test solutions. These test solutions were co-incubated with HSF cells for 3 h at 3rC. Subsequently, the test solutions were removed and the cells were washed twice with 100fLi PBS, overlaid with 50fLi EMEM (5% FCS), incubated for 17 h at 37°C and challenged with VSV(MOl = 0.1).Antiviral activity was evaluated by 50% CPE 17 h post-infection. NO, not detected; NI, not inhibitory. a. Mitoxantrone was tested at a lower concentration because of toxicity. The 0.05 mM dye, 0.05 mMand 0.2 mM poly (A-U) and the dye/poly (A-U) combinations with a test agenVnucleotide raatio of 1/4 were assayed in triplicate for their ability to induce IFN-I3. Each 35-mm titre dish was seeded with 500000 HSF cells suspended in 2 rnl MEM supplemented with 2% FCS and incubated at 3rC and 5% CO 2 for 24 h. Each dye was combined with poly (A-U) to produce a dye/poly (A-U) test solution with a test agenVnucleotide ratio of 1/4 and a fixed poly (A-U) concentration of 0.2mM (0.05mM for DHAQ). Poly (A-U) alone was tested at concentrations ofO.05mM and 0.2mM. One ml of each test agent was combined with an equal volume of MEM (2% FCS) and incubated on confluent monolayers of HSF cells. After 3 h, each test agent was removed, the monolayer washed exhaustively with PBS and overlaid with 2 ml of MEM. After 24h, the IFN-containing supernatant was divided into two 1-ml aliquots. The first aliquot was combined with 1 ml of MEM and added to a second titre dish. To demonstrate that IFN-13 was produced, the second aliquot was combined with an equal volume of a 1 :1600 dilution of NIH anti-IFN-13antibody (G-028-501-568) for 1 h at 3rC and 5% CO2 before being added to a second titre dish. After 24h of incubation at 3rC and 5% CO2 , the HSF cells were challenged with VSV (100 PFU/plate). After 1 h, the supernatant was removed and the cells overlaid with 0.5% methylcellulose. After a 48 h lncubation at 37°C and 5% CO2 , the methylcellulose was aspirated and the cells were stained with 0.5% crystal violet (in 70% ethanol) for 30 min. The culture plates were then air dried and scored for plaques. Poly (I) • poly (C) (PL Biochemicals) was employed as the positive control, while plain medium served as the negative control. Theanti-IFN-13 antibody was mixed with VSV to determine the non-specific inactivation of the VSV by the antibody. activity occurs only when EB is added to poly (A-U) or poly (G-C).
The fifth set of experiments evaluated the IFN-inducing capacity of the 0.2 mMpoly (A-U), of each 0.05 mMdye test solution, and of the dye/poly (A-U) combinations. The results shown in Table 7 demonstrate that all of the 0.05 mM dye test solutions alone, 0.2 mM poly (A-U) and the dye/poly (A-U) combinations with a drug/ribonucleotide (D/P) ratio of 1/4 induced IFN-f3.The IFN induced by the 0.2 mM poly (A-U) alone reduced the number of plaques by 30% (P < 0.01). The dyes alone reduced the number of plaques by the following amounts: ADR, 11% (P < 0.01); CHL, 21% (P < 0.02); DHAQ, 8% (P < 0.01); DMHE, 21% (P< 0.001); DMN, 10% (P< 0.05); EB, 16% (P< 0.01); HAQ, 13% (P< 0.01); NMHE, 20% (P< 0.001); PI, 16% (P< 0.01); and QUI, 11% (P< 0.05).The dye/poly (A-U)combinations reduced the number of plaques by the following amounts: ADRIpoly (A-U), 32% (P < 0.001); CHUpoly (A-U), 65% (P < 0.001); 0.0125mM DHAQ/ 0.05mM poly (A-U), 2% (P < 0.001); DMHEIpoly (A-U), 24% (P < 0.001); DMN/poly (A-U), 29% (P < 0.001); EB/poly (A-U), 31% (P < 0.001); HAQ/poly (A-U), 27% (P < 0.001); NMHEIpoly (A-U), 24% (P < 0.001); PI/poly (A-U), 32% (P < 0.001); and QUI/poly (A-U), 90% (P < 0.001). Addition of 1 ml of a 1/1600 dilution of NIH human IFN-f3 antiserum to an equal volume of supernatant from dye-treated cells, poly (A-U)-treated and dye/poly (A-U)treated cells, destroyed the antiviral activity of all the test agents, except the CHUpoly (A-U) and the QUI/poly (A-U) combinations. The results from the IFN neutralization assay demonstrate that, except for CHUpoly (A-U) and the QUI/poly (A-U) combinations, the IFN-inducing capability of the dye/poly (A-U) combinations closely approximates the sum of the IFN-inducing capabilities of the poly (A-U) and the dyes employed. These results suggest that the majority of the dyes tested potentiate the antiviral activity of the poly (A-U) without affecting the amount of IFN induced.
Discussion
Water-soluble anionic polymers are known to manifest significant inhibitory effects on bacteria, fungi and viral replication (Raj and Pitha, 1980; Zarling, 1981) . Many of the antiviral effects of these anionic polymers correlate with their ability to induce IFN (Ottenbrite and Butler, 1984) . Double-stranded RNA polymers are the most potent, least toxic and most widely active inducers of IFN both in vivo and in vitro (Pitha and Kusiak, 1984; Greene et el., 1984) . Poly (A-U) is of special interest because it has been shown to possess a potentiated antiviral activity and an enhanced resistance to endonuclease degradation when it is thermally activated in the presence of divalent cations (Ca 2 +, Mg 2 +) (De Clercq et aI., 1971; De Clercq, 1977) . Diederich et al. (1972 Diederich et al. ( , 1973 observed that cationic dyes such as toluidine blue 0 and methylene blue also potentiate the antiviral and IFN-inducing activities of dsRNA in L cells. The basis of this potentiated antiviral activity has not been elucidated, but an interaction of the dyes with the polyribonucleotide has been suggested. This hypothesis is plausible because both methylene blue and toluidine blue 0 specifically bind to RNA (Marcinka, 1972) ,with intercalation being the probable primary mode of binding (Popa and Bosch, 1969) . Sehgal et al. (1975) demonstrated that while neutral red or chloroquine alone were not effective IFN inducers, treatment of human diploid fibroblasts with these dyes 2.5 to 3.5 h after poly (I) . poly (C) treatment potentiated IFN induction 16-64fold and 4-16-fold respectively. The enhanced IFN induction has been attributed to an increase in the rate and duration of the period of IFN production induced by the drugs' inhibition of RNA and protein synthesis. In a previous study, we designed experiments to examine systematically and quantify the modulation of the antiviral activity of poly (A-U) by ethidium bromide and propidium iodide (Jamison et aI., 1990a) . Ethidium bromide (EB) and propidium iodide (PI) were employed because they are known to bind to double-stranded nucleic acids, primarily by intercalation, with a maximum intercalative binding of one ethidium molecule per two base pairs (one EB perfour nucleotides). The results of our previous study demonstrated that when the poly (A-U) concentration is fixed at 0.05 mM or 0.2 mM and the EB (or PI) concentration is varied to produce variable EB (or PI)/ribonucleotide ratios ranging from 1: 16 to 2: 1, optimal potentiation of antiviral activity is observed at an EB (or PI)/ribonucleotide ratio in Intercalating dyes and RNA 341 the regien of 1 :4, corresponding to one EB or PI molecule per four nucleotides. The results of these in vitro antiviral assays suggest that an intercalative dye-nucleic acid interaction may be responsible for the enhanced antiviral activity.
The results of structural studies on DNA and dsRNA illustrate that DNA displays a structural polymorphism induced by changes in humidity and ionic strength as well as oligonucleotide sequence, while dsRNA exhibits a structural conservatism in which the dsRNA is restricted to the A or A' forms (Saenger, 1984) . In contrast to B-form DNA, which is characterized by base pairs which are pierced by the helix axis with major and minor grooves of nearly equal depth, A-form dsRNA is characterized by the displacement of the helix axis towards the major groove. This displacement produces a macroscopic arrangement in which the polynucleotides are wrapped around the helix axis creating an open cylinder with a deep, narrow major groove on the inner surface of the cylinder and a reduced, shallow, wide minor groove on the outer surface. The major groove on the inner surface of the cylinder is accessible only to water molecules and metal ions (Saenger, 1984) . This suggests that both the major and minor grooves are available for intercalation in B-form DNA while only the minor groove is readily accessible for intercalation in A-form dsRNA. Therefore, if intercalation is necessary for a dye to potentiate the antiviral activity of poly (A-U), one would expect minor groove and minor/ major groove intercalating dyes (but not major groove intercalating dyes) to potentiate the antiviral of poly (A-U). Major groove intercalating dyes should not potentiate the antiviral activity of poly (A-U) because of their inability to form an intercalative complex with poly (A-U) due to the inaccessibility of the major groove. To test this hypothesis, experiments were designed to examine and quantify the modulation of the antiviral and IFN-inducing activities of poly (A-U) and poly (G-C) by cationic dyes that are known to intercalate into double-stranded nucleic acids.
The interaction of double-stranded nucleic acids with some of the intercalative dyes employed in this study has been well characterized by a variety of techniques including single crystal X-ray analysis of intercalative dye-ribonucleotide complexes (Waring, 1965; Berman and Young, 1981) . The results of spectroscopic studies (Douthart et al., 1973; Nelson and Tinoco, 1984) and crystallographic studies (Tsaiet al., 1975; Tsai, 1978) indicate that ethidium and propidium bind to double-stranded nucleic acids primarily by intercalation from the minor groove with a maximal intercalation of· one dye molecule per four nucleotides. ADR and DMN are known to bind to doublestranded nucleic acids primarily by intercalation from the minor groove with a maximal intercalation of one drug molecule per six nucleotides (Calendi et al., 1965; Doskocil and Fric, 1973; Gabbay et al., 1976; Quigley et al., 1980; Chaires et et., 1982; Wang et a/., 1987) . Acridine orange and proflavine bind to double-stranded nucleic acids primarily by intercalation from the major groove (Seeman et el., 1975; Berman et aI., 1979; Reddy et a/., 1979; Wang et a/., 1979; Westhof and Sundaralingam, 1980) . Drummond et at. (1965) have shown that 9-aminoacridine binds to double-stranded nucleic acids primarily by intercalation, with maximal intercalation of one molecule per four nucleotides. Analysis of a 9-aminoacridine: 5-iodocytidy-Iyl (3'-5')guanosine crystalline complex demonstrated two modes of intercalative binding and suggested that 9-aminoacridine intercalates into double helical nucleic acids from either the major or minor grooves . Finally, the results of single crystal X-ray analysis indicated N 2-methyl-9-hydroxy-ellipticine acetate (NMHE)and N 2-N6-dimethyl-9-hydroxy-ellipticine chlorohydrate (DMHE) intercalate into double-stranded nucleic acids from either the major or minor grooves (Jain et a/., 1979; Dodin et aI., 1988; Sizun etal., 1988; Schwaller etal., 1989; Courseille et aI., Eleventh European Crystallographic Meeting, Vienna, Austria, 1988) .
For the remainder of the intercalative dyes employed in the present study, the precise mode of intercalation has not been elucidated by single crystal X-ray analysis. Ametantrone and mitoxantrone have been shown to intercalate into to natural, double-stranded RNA, poly (A) . poly (U), calf thymus DNA and synthetic DNA duplexes with a maximum intercalation of one drug molecule per four to six nucleotides. Quinacrine, chloroquin and quinine are known to intercalate into doublestranded nucleic acids (Marguez et aI., 1974; Olmstead et a/., 1975; Davidson et a/., 1977; Feigon et el., 1984; Kwakye-Berko and Meshnick, 1989) . This intercalative binding has been characterized for quinacrine, which intercalates with a maximum ratio of one dye molecule per four nucleotides (Kurnick and Radcliffe, 1962) . Toluidine blue 0 (TBO) and methylene blue (MB) are two thiazine dyes that have been shown to bind to the double-stranded nucleic acids primarily by intercalation (MUlier and Crothers, 1975; MUlier et aI., 1975) . Finally, 9-acridinylmethanesulphonanilide (AMSA) and its derivatives that were employed in this study are known to intercalate into double-stranded nucleic acids (Wilson et a/., 1981; Feigon et a/.,1984; Elmore et aI., 1988) .
In the present study, 10 of the 20 dyes tested (ADR, CHL, DMN, DHAQ, DMHE, EB, HAQ, NMHE, PI and QUI) potentiated the antiviral activity of poly (A-U)(Table5). One of the most active dyes, ethidium bromide, was combined with poly (A-U), poly (G-C), poly (I) . poly (C) and poly d(A-T) in an effort to determine if the enhancement phenomenon is sensitive to the base sequence of the polynucleotide. The results of these experiments (Table 6) indicate only the EB/poly (A-U) and the EB/poly (G-C) combinations display enhanced antiviral activity. Further-more, the ability of ethidium to potentiate the antiviral activity of a polyribonucleotide correlates well with the affinity of ethidium for the polyribonucleotide. Ethidium exhibits association constants for poly (A) . poly (U) and for alternating co-polymers that are twofold greater than the association constant for poly (I) . poly (C). Similarly, ethidium potentiates the antiviral activity of poly (A-U), but not the antiviral activity of poly (I) . poly (C). However, while ethidium exhibits a strong affinity for poly d(A-T), the EB/poly D(A-T) combination does not produce any measurable antiviral activity. The strong affinity of ethidium for alternating co-polymers is not surprising. A number of investigators (Krugh et sl., 1975; Krugh and Reinhardt, 1975; Bresloff and Crothers, 1981) have established that ribonucleotides and deoxyribonucleotides with a pyrimidine-3'-5'-purine sequence, such as poly (A-U), are the preferred binding site for ethidium because their interstrand base overlaps stabilized intercalation and because intercalation into these sequences is energetically favourable. The inactivity of the EB/poly d(A-T) combination suggests that IFN induction may also be required for potentiated antiviral activity. The results of these studies suggest that intercalation of the dye is necessary, but not sufficient to potentiate the antiviral activity of polyribonucleotides.
The results from the IFN neutralization assay (Table 7) demonstrate that the majority of the intercalative dyes examined in this study potentiate the antiviral activity of the poly (A-U)without affecting the amount of IFN induced. In one of our previous studies (Jamison et aI., 1990b) , photomicrographs of HSF cells treated with 0.05mM NMHE alone or with a NMHEIpoly (A-U) combination with a NMHEIribonucleotide ratio of 1 :4 and a fixed poly (A-U) concentration of 0.2 mM demonstrated that incubation with NMHE alone resulted in the accumulation of NMHE in perinuclear vesicles, while incubation with the NMHEIpoly (A-U) combination resulted in the accumulation in the nucleolus. These results suggest that poly (A-U) affects the kinetics of uptake as well as the subcellular distribution of the NMHE. The intercalation of these dyes into nucleic acids is believed to be responsible for a wide variety of pharmacological effects including: inhibition of DNA transcription and RNA processing (Snyder et aI., 1971; Zunino et sl., 1972; Survanarayana and Burma, 1975; Liau et aI., 1977; Kapuscinski et a/., 1981; Safa et aI., 1983; Charcosset et a/., 1983; Komiyama et aI., 1983; Kriebardis et sl., 1984) ; inhibition of the cell cycle (Kapuscinski and Darzynkiewicz, 1985) ; inhibition of thymidine incorporation into DNA and uridine incorporation into RNA (Traganos et aI., 1980) ; formation of DNA-protein crosslinks as well as the formation of protein-associated and nonprotein-associated DNA breaks (Bowden et el., 1985; Cohen et aI., 1980; Tewey et a/., 1984) ; and condensation of nucleic acids in solution and in situ (Kapuscinski and Darzynkiewicz, 1984 , 1986 . These observations suggest that mechanisms other than intercalation and IFN induction may also be involved in the potentiation of the antiviral activity.
In this study, the human foreskin fibroblast-vesicular stomatitis virus (HSF-VSV) bioassay system was employed to systematically examine the effects of intercalating dye-induced perturbations on the antiviral activity of poly (A-U).Dyesthat intercalate from the minor groove, the major groove, or either the minor or major groove as well as dyes whose mode of intercalation is not known were tested in this study. Neither poly (A-U) alone nor each intercalative dye was an efficacious antiviral agent. When poly (A-U)was combined with the minor groove intercalating dyes (ethidium bromide, propidium iodide, adriamycin or daunomycin) or the minor/major groove intercalating dyes (9-aminoacridine, DMHE or NMHE) at a dye/ribonucleotide ratio of 1/4, the antiviral activity of the poly (A-U) was potentiated eight-to 22-fold. When poly (A-U) was combined with the major groove intercalating dyes (acridine orange or proflavine), no synergism was observed. When poly (A-U) was combined individually with 11 other intercalating dyes whose mode of intercalation was not known, four of the dyes (chloroquine, DHAQ, HAQ and quinine) potentiated the antiviral activity of the poly (A-U) nine-to 10-fold. This suggests that these four dyes may intercalate into double-stranded nucleic acids from the minor groove. Ten (ADR, CHL, DMN, DHAQ, DMHE, EB, HAQ, NMHE, PI and QUI) of the 20 dyes evaluated in this study exhibited synergism with poly (A-U),as quantified by the fractional inhibitory concentration index. IFN neutralization assays demonstrated that, except for the chloroquine/poly (A-U)and the quinine/poly (A-U)combinations, the IFN-inducing capability of the dye/poly (A-U) combinations closely approximates the sum of the IFN-inducing capabilities of the poly (A-U) and the dyes employed. These results suggest that the majority of the dyes tested potentiate the antiviral activity of the poly (A-U) without affecting the amount of IFN induced. When ethidium was combined with a variety of polynucleotides, only the alternating ribonucleotide co-polymers [poly (A-U) and poly (G-C)] exhibited potentiated antiviral activity. The polyribonucleotides that exhibited the potentiated antiviral activity also exhibited the highest intercalative binding affinity for ethidium and are known to induce IFN. However, alternatlnq deoxyribonucleotide co-polymers, which exhibited a strong intercalative binding affinity for ethidium, did not induce IFN and lacked antiviral activity. These results suggest that intercalation of the dye as well as IFN induction may be necessary to potentiate the antiviral activity of polyribonucleotides. Our previous work (Jamison et aI., 1990b) with the minor/major groove intercalating dye, NMHE, demonstrated that poly (A-U) affects the kinetics of uptake as well as the SUbcellular Intercalating dyes and RNA 343 distribution of the dye. Like NMHE, all the dyes employed in these studies that potentiated the antiviral activity of poly (A-U) accumulated in the nucleolus. These results suggest that formation of a dye-poly (A-U) complex may alter the kinetics of uptake of the dyes and direct the dyes to the nucleus (nucleolus). Since dsRNA is known to directly activate at least 23 genes, including the IFN response genes (IRG), it is possible that the poly (A-U) and the intercalative dyes directly activate the IRGs, whose products then induce and maintain the antiviral state (Lammers et aI., 1988) . While the induction of many of these genes occurs at the transcriptional level and does not require protein synthesis, the shut-off mechanisms of these genes often require de novo protein synthesis (Fujita _ and Kohno, 1981) . Many of the intercalative dyes employed in these studies impair RNA synthesis and processing or inhibit protein' synthesis (Minor and Dimmock, 1985) . This inhibition may prolong the antiviral state by affecting the kinetics of shut-off of the IRG or by affecting the synthesis and processing of viral and cellular RNA.The structural similarity of NMHE and the active dyes employed in this study suggests that a dye-poly (A-U) complex may have produced the enhanced antiviral activity by altering the kinetics of uptake of the dyes; by directly activating blocks of IRG; by affecting the kinetics of shut-off of these genes; or by impairing the synthesis and processing of viral and cellular RNA.
Materials and Experimental procedures
The poly (A-U), poly (deoxyadenylate-deoxythymidylate) [poly d(A-1)] and poly (guanylate-cytidylate) [(poly (G-C)] (M,W = 80000-100000) employed in this study were purchased from Biogenics Research Corporation, Chardon, OH. The poly (I) . poly (C) employed in this study was purchased from P.L. Biochemicals, Piscataway, NJ. Adriamycin, daunomycin, 9-aminoacridine, ethidium bromide, propidium iodide, and gentamicin sulphate were purchased from Sigma Chemical Company, St Louis, MO. Acridine orange (CI46005), methylene blue (CI52015), toluidine blue 0 (CI 52040) and proflavine were purchased from Aldrich Chemical Company, Milwaukee, WI. Eagle's MEM with Earle's salts and foetal bovine serum were purchased from K.C. Biological, Lexexa, KS. The NMHE and DMHE were kindly supplied by Dr Christian Courseille, University of Bordeaux I, France. The ametantrone (HAQ) and mitoxantrone (DHAQ) were kindly provided by Dr Jan Kapuscinski of the Sloan-Kettering Institute for Cancer Research, Rye, NY. The amsacrine (AMSA) and its 3'-me" 'vxy, N-phenyl and o-AMSA derivatives were kindly supplied by Dr David Graves, University of Mississippi, MS. The polynucleotides and the intercalative dye solutions were prepared by dissolving desired concentrations in buffer A (0.15M NaCI, 0.005M NaH 2P04 and Na2HP04, pH 7.2) at 4°C. The concentrations of the poly (A-U) [E260 (molar absorptivity) = 6.1 x 10 3 ], poly d(A-1) (E257 = 6.7 x 10 3 ) , poly (G-C) (E260 = 6.4 x 10 3 ) (Biogenics Research Corporation, 1979) , poly (I). poly (C)(E260 = 4.9 x 10 3 ; P.L. Biochemicals) and the dye solutions were determined spectrophotometrically using a Gilford Model 250 spectrophotometer (Table 8 ).All test solutions were pipetted into [AO] = ---------(5.6 x 10 4 -4.3 X 10 3 OD 492) E47B = 1.15 X 10 4 E645 = 7.05 X 10 3 E40' = 8.89 x 10 4 E43B = 1.22 X 10 4 E432 = 1.32 X 10 4 E433 = 1.24 X 10 4 E432 = 1.21 X 10 4 E257 = 1.5 X 10 4 E477 = 1.15 X 10 4 E31B = 2.48 x 10 4 E310 = 2.9 X 10 4 E4BO = 5.45 X 10 3 0.0034 mg/ml, EBB5 = 7,79 x 10 4 EBB2 = 8.36 x 10 3 E444 = 4.1 X 10 4 E494 = 5.83x 10 3 E424 = 7.27 X 10 4 E249 = 3.16 X 10 4 0.0045 mg/ml, EB29 = 3.97 x 10 4 sterile glass vials and serially diluted with phosphate-buffered saline (PBS) in 12 twofold dilutions.
In the first set of experiments, poly (A-U) alone and each dye alone were co-incubated with HSF cells. Each was assayed at 10 concentrations ranging from 0.0008mM to O.4mM. The role of these dyes in modulating the antiviral activity of poly (A-U) was examined by experiments in which the concentration of poly (A-U) was fixed at 0.05 rnu, 0.1 mM or 0.2 mM, while the dye concentration was varied to produce variable dye/nucleotide ratios ranging from 1/16 to 2/1. Antiviral activity was tested using the methods that have been described in our previous paper . Each well of a Corning 96-well, flat-bottomed microtitre plate was seeded with 20000 human foreskin fibroblasts cells (M.A. Bioproducts, Walkersville. MD; MHRF) suspended in 50 ILlof Eagles' minimum essential medium (MEM; Gibco, Grand Island, NY) supplemented with 5% foetal calf serum (FCS; Gibco), pH 7.4. and each titre plate incubated at 37°C in 5% CO 2 for 24 h. Once confluency was attained, the overlying growth medium was removed and the cells washed twice with 100 ILl of PBS per well. Specifically, dye or polynucleotide alone or dye/polynucleotide combinations were co-incubated with HSF cells for 3 h. The test solutions were decanted and the HSF cells washed twice with 100 ILl of PBS, overlaid with 50 fl.1 of MEM for 17 h and challenged for 17 h with VSV at multiplicity of infection 0.1. After the viral challenge was completed, the 50% cytopathic effect (50% CPE) end-point was assessed subjectively for each column. with NIH human fibroblast IFN reference standard (G-023-902-527) (Research Reference Reagents. 1979) and poly (I)· poly (G) reference standard (G-020-901-090) (Research Reference Reagents, 1975) in each titre plate providing corroboration. The fractional inhibitory concentration (FIG)index equation, as described by Elion et el, (1954) and by SOhnel (1990) . was employed to evaluate synergism, additivism or antaqonisrn, FIC is defined by the equation: E~ocomb/E~oalone+ ED~ocomb/ED~oalone = FIC, where E~oa'one and ED~oa'one are concentrations of each dye alone and oligoribonucleotide alone at the 50% CPE endpoint; and E~ocomb is the concentration of dye (A)in combination with oligoribonucleotide (B) yielding CPEso. and ED~ocomb is the concentration of oligoribonucleotide (B) in combination with dye (A) yielding CPE so. A FIC < 1.0 indicates the combination is synergistic, while a FIC > 1.0 indicates the combination is antagonistic. A FIC = 1.0 indicates the combination is additive (or indifferent). The ability of dye, poly (A-U) and the dye/poly (A-U) combinations to induce IFN was tested in triplicate in 35-mm titre dishes using the method of De Clercq and Torrence (1977) . Each 35-mm titre dish was seeded with 500000 HSF cells suspended in 2 ml MEM supplemented with 2% FCS and incubated at 37"C and 5% CO 2 for 24 h. Each dye was combined with poly (A-U)to produce a dye/poly (A-U) test solution with a dye/nucleotide ratio of 1/4 and a fixed poly (A-U) concentration of 0.2 mM. Poly (A-U) alone was tested at a concentration of 0.2 mM. Each dye alone was tested at a concentration of 0.05 mM. One-millilitre of each test agent was combined with an equal volume of MEM (2% FCS) and incubated on confluent monolayers of HSF cells. After 3 h, each test agent was removed, the monolayer washed exhaustively with PBS and overlain with 2 ml of MEM. After 24 h, the IFN-containing supernatant was divided into two t-rnl aliquots. The first aliquot was combined with 1ml of MEM and added to a second titre dish. To demonstrate that IFN-13 was produced, the second aliquot was combined with an equal volume of a 1 : 1600 dilution of NIH sheep antiserum to human fibroblast IFN (G-028-501-658) for 1hat 37"C and 5% CO 2 before being added to a second titre dish. After 24 h of incubation at 37"C and 5% CO2 , the HSF cells were challenged with VSV (100 PFUIplate). After 1h, the supernatant was removed and the cells are overlain with 0.5% methylcellulose. After a 48h incubation at 37°C and 5% CO 2 , the methylcellulose was aspirated and the cells stained with 0.5% crystal violet (in 70% ethanol) for 30 min. The culture plates were then air-dried and scored for plaques. Poly (I) . poly (C) (P.L. Biochemicals) was employed as the positive control while plain medium served as the negative control. The anti-lFN-13 antibody was mixed with VSV to determine the non-specific inactivation of the VSV by the antibody.
